skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

52 Total results for product and free and sample content found

Scrip

The Microbiome, An Infographic

23 Mar 2017

Changing the composition of the microbiome, the multitude of bacteria, fungi, protozoa and viruses that reside in or on our bodies, or the way the microbiome interacts with its human host, could lead to novel therapeutic approaches to disease. Inflammatory bowel disorders, Clostridia-associated diarrhea and obesity are all potential targets for microbiome altering medicines.

Topic Research

Pharmaprojects

Pharma R&D By Numbers

By Ian Lloyd 22 Mar 2017

Welcome to Pharmaprojects' 2017 review of trends in pharmaceutical R&D.

Topic Drug review Deal trends Company analysis

Datamonitor Healthcare

Approval of the first medications targeting NASH patients

16 Mar 2017

Since there are currently no approved medications for the treatment of NASH, the first medications that are approved will be highly sought after in the industry.

Topic Drug review

Datamonitor Healthcare

Non-small cell lung cancer (NSCLC)

16 Mar 2017

The value of the non-alcoholic steatohepatitis (NASH) market will rapidly increase with the approval of the first medications indicated for the treatment of this disease. Download Your Complimentary Infographic On NASH Now!

Topic Cancer

Datamonitor Healthcare

Discover Datamonitor Healthcare's Cystic Fibrosis Infographic

07 Mar 2017

Over the last few decades, there have been steady improvements in the prognosis of patients suffering from cystic fibrosis.

Topic Rare Disease

Biomedtracker

Want to find out more about the future of the Pharma Industry?

28 Feb 2017

Biomedtracker's Early 2017 Outlook Infographic shows the igh Impact Catalysts that will have an effect of the future of the Pharam Industry

Topic Drug approval Drug review

Datamonitor Healthcare

Explore future changes in the multiple sclerosis market

08 Nov 2016

Increase your knowledge of the multiple sclerosis (MS) market by taking a tour of the key highlights from our forecast report

Datamonitor Healthcare

Ensure your successful entrance into the ovarian cancer market in the seven major markets

25 Oct 2016

Combine the strengths or Trialtrove and Datamonitor Healthcare to ensure your successful entrance into the ovarian cancer market in the 7 major markets

Topic Brexit

Datamonitor Healthcare

An exploration Rheumatoid Arthritis overview

20 Oct 2016

Despite key markets pressures, the rheumatoid arthritis (RA) market is forecast to continue to grow over the next 10 years. Our RA coverage highlights where the opportunities remain, with a detailed look into the future of the RA treatment.

Topic Arthritis

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: